PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 24, 2024Frontiers in Medicine5 citationsOpen Access

Regional diversity in drug-induced lung diseases among the USA, European Union, and Japan

View Full Paper
JSJun SatoRSRyo SadachiTKTakafumi Koyama

Key Points

Key points are not available for this paper at this time.

Abstract

Drug-induced lung disease (DILD) is a considerable and potentially fatal adverse event with poorly understood risk factors. Large-scale, data-driven analyses investigating regional discrepancies in DILD incidence are lacking. The aim of this study was to investigate the potential association among DILD prevalence, regional differences and other factors based on large-scale data base.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sato et al. (2024) studied this question.

synapsesocial.com/papers/68e57799b6db643587517bdchttps://doi.org/10.3389/fmed.2024.1390083
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer2016 · 765 citations
  2. 2Interstitial Lung Disease in Japanese Patients with Lung Cancer2008 · 490 citations
  3. 3Antibody Drug Conjugates for Cancer Therapy2015 · 303 citations
  4. 4Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors2018 · 2,679 citations
  5. 5New developments for antibody-drug conjugate-based therapeutic approaches2016 · 257 citations